openPR Logo
Press release

Apixaban Market – Dynamics Trends and Growth

07-23-2018 04:15 PM CET | Health & Medicine

Press release from: Pharmaceutical Report

Apixaban is a Food and Drug Administrator (FDA) approved anticoagulant used for the treatment of venous thromboembolic events (blood clot) that forms within a vein. Venous thromboembolic events (VTE) can occur without any prior symptoms or warning signs and can go undiagnosed and unrecognized by a healthcare professional. Symptoms that do appear may be associated with pulmonary embolism (PE) or either deep vein thrombosis (DVT) such as pain in the calf, swelling in the ankle or foot, redness or noticeable discoloration spots, rapid breathing, chest pain, and others. Apixaban is sold under the trade-name of Eliquis. Factor Xa is a trypsin-like serine protease that plays a key role in blood coagulation cascade. Apixaban mechanism works on inhibiting factor Xa, which indirectly decreases the clot formation stimulated by thrombin. Apixaban is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The recommended dose of Eliquis is 5mg orally twice a day. Apixaban is available in the market as capsules and tablet form.

Click To Continue Reading On
https://www.coherentmarketinsights.com/ongoing-insight/apixaban-market-1898

Apixaban Market – Dynamics

Increasing prevalence of venous thromboembolism related conditions is expected to aid in growth of the apixaban market. For instance, according to International Society on Thrombosis and Haemostasis 2014 facts, revealed that around 10 million cases of venous thromboembolism occur annually across low, middle and high income countries. Moreover, increasing therapeutic indications for apixaban is expected to boost the apixaban market growth. For instance, in 2014, the U.S. Food and Drug Administration approved Eliquis for the treatment of deep vein thrombosis (DVT) prophylaxis and pulmonary embolism (PE) and also for the reduction in risk of recurrent PE and DVT following initial therapy. Furthermore, government and private organizations are significantly investing capital in healthcare research and development and this is also likely to propel growth of the Apixaban market. However, adverse effects of apixaban such as increased risk of thrombotic events after premature discontinuation and bleeding is expected to hamper adoption of this. This in turn is expected to adversely affect growth of the market. According to a study published in the Current Medical Research and Opinion 2017 stated about the bleeding risk associated with use of apixaban.

Get The Holistic SAMPLE With Research Methodology:
https://www.coherentmarketinsights.com/insight/request-sample/1898

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: https://www.coherenttimes.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Apixaban Market – Dynamics Trends and Growth here

News-ID: 1141081 • Views: 314

More Releases from Pharmaceutical Report

Pharmaceutical Robots Market Forecast 2018- 2026: Kawasaki Heavy Industries,
Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Kawasaki Heavy Industries ,Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are the prominent players in the global pharmaceutical robots market. The global pharmaceutical robots market is anticipated to reach 452.7 million by 2025 and estimated to reach
Grow Owning to Innovations In Oncology Nutrition Market
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
FMD Vaccine Market - Shield against Economic Loss
Foot and Mouth Disease (FMD) causes repetitive outbreak around world thereby causing economic and social damage. Preventing foot and mouth disease is the only sustainable and viable options, which can be done only though the vaccination for FMD, which is expected to drive growth of the foot and mouth disease vaccine market. According to paper published by the Food and Agricultural Organization (FAO) and World Organization for Animal Health (OIE),
Divalproex Sodium Market Competitive Landscape,Regional Insights
Increasing prevalence of bipolar disorders around the globe is propelling the divalproex sodium market growth. For instance, according to study published in JAMA Psychiatry Journal 2012, in a combined sample of 61,392 adults from 11 countries, the total lifetime prevalence of bipolar disorder-I was 0.6%, and 0.4% for bipolar disorder-II and subthreshold bipolar disorder was 1.4%, yielding a total prevalence estimates bipolar disorder spectrum of 2.4% globally. Moreover, rising patient pool

All 5 Releases


More Releases for Apixaban

Apixaban Market Research Report Up to 2031
Visiongain has published a new report on Apixaban Market Report to 2031. Market is segmented By Dosage Form (Capsule, Tablet), By end user (Hospitals, Retail Pharmacies, Online Pharmacies, Others). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Apixaban Companies. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/apixaban-market/#download_sampe_div The study covers detailed and insightful chapters on market overview, market
Global Apixaban Market 2021 - Industry Insights, Drivers, Top Trends, Global Ana …
Apixaban The report titled “Apixaban Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026” utilizing diverse methodologies aims to examine and put forth in-depth and accurate data regarding the global Apixaban Market. The report is segregated into different well-defined sections to provide the reader with an easy and understandable informational document. Further, each section is elaborated with all the required data to gain knowledge about the market before entering
Global Apixaban API Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Apixaban API market analysis, which studies the Apixaban API's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global "Apixaban API Market 2020-2025" Research Report categorizes the global Apixaban API market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
Global Apixaban Market Research Methodology & Rapid Growth Till 2025
The“Apixaban Market: by dosage form (capsule and tablet), and end-users (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies and Others)– Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025”published and promoted by Zion Market Research provides in-depth segment analysis of the market being effective in several sectors, thereby providing valuable insights to the rivals. The global Apixaban Market report offers the realistic data gathered on the basis of various key factors such as
Apixaban Market | Risk Factors, Growth Strategies | Market Driving Factors, Fore …
The Apixaban Market report provides detailed profile assessments and current scenario revenue projections for the most promising industry participants. The Global Apixaban Industry report focuses on the latest trends in the Global and regional spaces on all the significant components, including the capacity, Market Players: Pfizer, Medichem, Polpharma, Beijing Cooperate Pharmaceutical, Centaur Pharmaceutical and more…. Get Exclusive Sample of Report on Apixaban market having 100 pages, profiling more than TOP
Apixaban Market - Size, Share, Outlook, and Forecast till 2026
Apixaban is an anticoagulant used to reduce blood clotting and risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is an oral factor Xa inhibitor and is sold under the trade name Eliquis. It was approved in Europe in 2012 and in the U.S. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE). Apixaban was developed in a joint